Therapeutic area intelligence for Pulmonary Embolism with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

RAMBO →

Registry →

Recent signals(3)

ClinicalAugust 3, 2026

Study on Echocardiographic PAP Changes for Pulmonary Embolism Risk Stratification

This study aims to evaluate the effectiveness of echocardiographic pulmonary artery pressure changes in predicting pulmonary embolism risk in emergency department patients.

ClinicalJuly 28, 2026

RAMBO trial evaluates pulmonary rehabilitation's impact post-pulmonary embolism

The RAMBO trial assesses the efficacy of pulmonary rehabilitation in patients with persistent dyspnea after anticoagulation for pulmonary embolism.

ClinicalJune 23, 2026

Registry Launched to Evaluate Thrombectomy for Pulmonary Embolism

A new registry has been initiated to collect data on the effectiveness and risks of thrombectomy in patients with pulmonary embolism.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.